Did you know that Brazil's medical device market is experiencing a surge, attracting billions in imports annually? This boom, however, is attracting not only legitimate businesses but also those looking to exploit loopholes.
In 2023, the U.S. Supreme Court affirmed invalidity of two Amgen patents based on a lack of enablement for broad genus claims that would potentially encompass millions of antibodies. The Court1.
IAM is a unique and timely intelligence service that treats IP as a business asset and tool rather than simply as a legal right, informing boardrooms worldwide.
On August 18, 2023, a district court in Washington D.C., affirmed the U.S. Copyright Office's refusal to register "A Recent Entrance to Paradise," a piece of artwork created by the Creativity Machine.